References
- Freda PU, Beckers AM, Katznelson L et al. Pituitary incidentaloma: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab.96(4), 894–904 (2011).
- Costello RT. Subclinical adenoma of the pituitary gland. Am. J. Pathol.12(2), 205–216 (1936).
- Ezzat S, Asa SL, Couldwell WT et al. The prevalence of pituitary adenomas: a systematic review. Cancer101(3), 613–619 (2004).
- Buurman H, Saeger W. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data. Eur. J. Endocrinol.154(5), 753–758 (2006).
- Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J. Clin. Endocrinol. Metab.91(12), 4769–4775 (2006).
- Fernandez A, Karavitaki N, Wass JA. Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin. Endocrinol.72(3), 377–382 (2010).
- Tabas JA, Hsia RY. Invited commentary – emergency department neuroimaging: are we using our heads? Comment on “Use of neuroimaging in US emergency departments”. Arch. Intern. Med.171(3), 262–264 (2011).
- Raja AS, Andruchow J, Zane R, Khorasani R, Schuur JD. Use of neuroimaging in US emergency departments. Arch. Intern. Med.171(3), 260–262 (2011).
- Vernooij MW, Ikram MA, Tanghe HL et al. Incidental findings on brain MRI in the general population. N. Engl. J. Med.357(18), 1821–1828 (2007).
- Freda P, Katznelson L, Molitch M. Patient guide to pituitary incidentaloma assessment and treatment. J. Clin. Endocrinol. Metab.96(4), 35A–36A (2011).
- Jaffrain Rea ML, Daly AF, Angelini M, Petrossians P, Bours V, Beckers A. Genetic susceptibility in pituitary adenomas: from pathogenesis to clinical implications. Expert Rev. Endocrinol. Metab.2, 195–214 (2011).
Website
- OECD. Medical technologies: CT scanners and MRI units. In: OECD Health at a Glance: Europe 2010. OECD Publishing (2010) www.oecd.org/health/healthataglance/europe